What this study is
The purpose of this study is to determine whether preoperative mobility device training is beneficial in reducing incidence of postoperative falls in patients undergoing elective foot and ankle surgery requiring a postoperative period of no weight-bearing.
What's being tested
- Preoperative mobility device(s) training
Intervention · OTHER
Patients in Group 1 (the intervention, that is the mobility device training group group) will receive training on the mobility device(s) with the physical therapy visit during their standard pre-operative care.
Study details
- Sponsor
- University of Alabama at Birmingham
- Conditions
- Injury; Muscle, Ankle, and Foot, Multiple
- Enrolling
- 250 people
- Starts
- 2019-09-09
- Est. completion
- 2027-05
- Design
- Open-label, randomized, parallel groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Age 18 and older
- Undergoing elective unilateral foot/ankle surgery
- Requiring a period of post-operative non-weight-bearing or partial-weight-bearing period as advised by the operating surgeon.
You can't join if
- Less than 18 years of age
- Wheelchair-bound patients
- Patients with history of previous use of post-operative mobility device(s)
- Patients with ankle fractures, patients with previously diagnosed condition(s) with cognitive, balance, mobility impairment
- Patients undergoing bilateral surgery
- Patients requiring follow ups longer than 6 weeks
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openUAB Hospital Highlands
Birmingham, Alabama, United States
- Ashish Shah, MD · Contact2059306722ashishshah@uabmc.edu
- Jessica McKnight · Contact2059306722jdmcknight@uabmc.edu
Recruiting
Study team
Sponsor
University of Alabama at Birmingham
Study ID IRB-300002190-001
Principal investigator
Ashish B Shah, MD
University of Alabama at Birmingham
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.